The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
It was savvy business to purchase Imagen Therapeutics' assets for almost nothing. They have the co-founder of Imagen on their staff, so they only need to keep working with their clientele. The new Inaphaea lab is already home to Imagen Therapeutics assets. Revenue this quarter is anticipated. They are already in discussions or negotiations with potential customers, so if a contract is signed and announced, stock prices should rise by double digits.
Everything is OK (even if the share price isn't). Our price would be 10 times greater if we were listed on Nasdaq.
Porky has 25k shares in Valirx. Why does Porky spend all his days/weeks writing long posts ?
Surely Porky's time is more valuable than their tiny investment ?
We have funds until the middle of 2024.
The CRO revenue will generate revenue soon.
Adam is the largest shareholder. If he thought changes were needed now, he would have made them. He can influence future change if need be. He's been in the industry for decades. I have total trust in Adam.
Adam was a 'shareholder representative'. He relayed the thoughts of shareholders to the company. It's no longer needed because anyone can contact Suzy or Kevin directly. They welcome contact.
The CRO plans are promising and look to be revenue generating very soon. Once the first contract lands expect double digit share price increases.
It was a 'virtual' AGM.
It must have been difficult for Adam. He has already lost serious 'paper' millions. With all his experience running a revenue generating CRO, you'd think he'd be on the board. Suzy has no experience running a revenue generating CRO.
We'll wait and see . . .
The recent acquisition of Imagen Therapeutics's assets was a brilliant move. Amazing price.
It fast tracks Valirx's CRO, Inaphaea BioLabs.
With strategy and good business sense like this I do think we'll be turning over revenue of £20 million+ within 3-4 years.
SP should be minimum 0.40p right now - we should if we were listed in the U.S.
Not sure I understand ....... you are unhappy with Suzy and Kevin but not voting them out ?
The most dissatisfaction is with Suzy Dilly - having read the 100s of negative posts on this BB. 'Full of confidence and unconcerned' ...
Suzy really shines when talking about the science; otherwise she looks nervous. Some people are like that. Years ago, when interviewed, Mark Zuckerberg of Facebook looked nervous. Certainly Suzy has a lot to lose if voted out.
Ken was ok.
Not sure what Stella adds? Not sure if she is liked by the shareholders either. She has very little to lose, so why would she worry?
Still think Adam should be added to the Board. Share price would triple on his appointment.